Sunday, September 8, 2024

Latest Posts:

BlueSnap appoints Bill Christensen as SVP of Acquiring & Risk

BlueSnap, a global payment orchestration platform for leading B2B and B2C businesses, has appointed Bill Christensen as SVP, of Acquiring & Risk.

Jitterbit Unveils AI-Infused Platform 

Jitterbit Unveils AI-Infused Harmony Platform to Accelerate Business Transformation

Spotify founders’ £299 Full Body Scan, Neko Health, launches in the UK

Neko Health Brings a First-of-Its-Kind £299 Body Scanner to...

Global recovery could be faster if COVID vaccine made available to all

“Sharing vaccines or sharing other tools actually helps the world to recover together. The economic recovery can be faster and the damage from COVID-19 could be less,” Tedros Adhanom Ghebreyesus, World Health Organization Director General, in an online panel discussion with members of the Aspen Security Forum in the United States moderated by the NBC network. 

“Vaccine nationalism is not good, it will not help us,” he said in an allusion to the competitive scramble of nations and pharmaceutical researchers to come up with an effective vaccine and order as many doses as possible in advance. 

Tedros had said on Monday that while the coronavirus was the biggest health emergency since the early 20th century, the international race for a vaccine was also “unprecedented”. 

“We must seize this moment to come together in national unity and global solidarity to control COVID-19,” he told Thursday’s forum. “No country will be safe until we are all safe.” 

WHO emergencies director Michael Ryan, asked about a proposed Russian vaccine, told the panel that trial data was needed to ensure any vaccines are safe and effective. 

Ryan also said authorities should be able to demonstrate the efficacy of a coronavirus vaccine via traditional clinical trials rather than “human challenge” studies. 

He was referring to the intentional exposure of vaccinated volunteers to a virus to see whether the vaccine works. 

U.S. President Donald Trump said on Thursday it was possible the United States would have a coronavirus vaccine before the Nov. 3 election – a more optimistic forecast than timing put forth by his own White House health experts. 

Trump has accused the WHO of becoming a puppet for China – where the coronavirus outbreak first surfaced late last year – during the COVID-19 pandemic and given notice that the United States will quit the agency in a year’s time. 

The United States is the biggest overall donor to the WHO and had contributed more than $800 million by the end of 2019 for the 2018-19 biennial funding period. 

But Tedros, who has denied that the WHO answers to China or any other country, told the panel that the main damage from the Trump administration’s move to exit the Geneva-based agency would not be the loss of funding. 

“The problem is not about the money, it’s not the financing…, it’s actually the relationship with the U.S. That is more important for the WHO – the void, not the financial. And we hope then U.S. will reconsider its position,” he said. 

 

Reported by Michael Shields and Ludwig Burger 

Sourced Reuters 

For more Leadership news follow i-invest Online. 

Latest

BlueSnap appoints Bill Christensen as SVP of Acquiring & Risk

BlueSnap, a global payment orchestration platform for leading B2B and B2C businesses, has appointed Bill Christensen as SVP, of Acquiring & Risk.

Jitterbit Unveils AI-Infused Platform 

Jitterbit Unveils AI-Infused Harmony Platform to Accelerate Business Transformation

Spotify founders’ £299 Full Body Scan, Neko Health, launches in the UK

Neko Health Brings a First-of-Its-Kind £299 Body Scanner to...

UK FinTech vacancies on the rise amid investment rebound

London is at the centre of a rapid increase...

Subscribe To Our Content

Don't miss

BlueSnap appoints Bill Christensen as SVP of Acquiring & Risk

BlueSnap, a global payment orchestration platform for leading B2B and B2C businesses, has appointed Bill Christensen as SVP, of Acquiring & Risk.

Jitterbit Unveils AI-Infused Platform 

Jitterbit Unveils AI-Infused Harmony Platform to Accelerate Business Transformation

Spotify founders’ £299 Full Body Scan, Neko Health, launches in the UK

Neko Health Brings a First-of-Its-Kind £299 Body Scanner to...

UK FinTech vacancies on the rise amid investment rebound

London is at the centre of a rapid increase...

Ørsted shuts down its last coal-fired heat and power plant

On 31 August 2024, Ørsted will shut down its...

BlueSnap appoints Bill Christensen as SVP of Acquiring & Risk

BlueSnap, a global payment orchestration platform for leading B2B and B2C businesses, has appointed Bill Christensen as SVP, of Acquiring & Risk.

Jitterbit Unveils AI-Infused Platform 

Jitterbit Unveils AI-Infused Harmony Platform to Accelerate Business Transformation

Spotify founders’ £299 Full Body Scan, Neko Health, launches in the UK

Neko Health Brings a First-of-Its-Kind £299 Body Scanner to the UK, Helping Doctors Find and Prevent Disease Neko Health, the preventative healthcare technology company co-founded by...

LEAVE A REPLY

Please enter your comment!
Please enter your name here